8.6
Drug Distribution as One-Compartment Model and Elimination by Nonlinear Pharmacokinetics: Overview
Drug administration can occur through various routes, each of which may result in a different process of elimination. This process is often mixed with…
Drug administration through various routes results in mixed drug elimination, involving both nonlinear and linear processes.
The metabolism of drugs yields different metabolites through parallel pathways. At low doses, metabolite formation follows first-order kinetics, but at higher doses, the metabolizing enzyme saturation induces nonlinear metabolite formation.
This elimination equation combines first-order and Michaelis-Menten kinetics. The first-order rate constant, k, represents the sum of all first-order elimination processes, and the second term of the equation signifies the saturable process.
For instance, niacin, undergoing extensive first-pass metabolism, exemplifies dosing rate specificity.
One metabolic pathway involves glycine conjugating to nicotinic acid to form nicotinuric acid.
Another one results in the formation of nicotinamide adenine dinucleotide, which is further metabolized into several metabolites.
Administering multiple doses of niacin extended-release tablets to treat hyperlipidemia results in saturation of these metabolic pathways, establishing a nonlinear relationship between the niacin dose and plasma drug concentration.
View the full transcript and gain access to JoVE Core videos
Q1: What is the difference between linear and nonlinear drug elimination?
Linear elimination follows first-order kinetics at all doses, where the elimination rate is proportional to drug concentration. Nonlinear elimination occurs when metabolizing enzymes become saturated at higher doses, causing the elimination rate to become independent of concentration. Mixed elimination involves both processes simultaneously, combining first-order and Michaelis-Menten kinetics to describe the saturable process.
Q2: How does enzyme saturation affect drug metabolism at different doses?
At low doses, metabolite formation follows first-order kinetics with constant elimination rates. At higher doses, metabolizing enzymes become saturated, inducing nonlinear metabolite formation where elimination capacity plateaus. This saturation creates a dose-dependent relationship between drug administration and plasma concentration, exemplified by niacin extended-release tablets used to treat hyperlipidemia.
Q3: Why does niacin metabolism demonstrate nonlinear pharmacokinetics?
Niacin undergoes extensive first-pass metabolism through multiple parallel pathways that are dosing-rate specific. One pathway involves glycine conjugation to form nicotinuric acid, while another produces nicotinamide adenine dinucleotide and additional metabolites. Multiple doses of niacin extended-release tablets saturate these conjugation pathways, establishing a nonlinear relationship between dose and plasma drug concentration.
Q4: What role do parallel metabolic pathways play in drug elimination?
A single drug can be metabolized into different metabolites through parallel pathways, each with distinct saturation characteristics. For example, sodium salicylate forms both a glucuronide and a glycine conjugate, with conjugation rates depending on available glycine. These competing pathways create complex elimination profiles where saturation of one pathway shifts metabolism toward others.
Q5: How do administration routes affect nonlinear drug elimination?
Intravenous infusion follows zero-order input with nonlinear elimination, maintaining constant drug delivery while saturable elimination processes occur. Oral administration involves first-order absorption combined with nonlinear elimination. These different input-elimination combinations require distinct mathematical equations to predict drug behavior and plasma concentrations over time.
Q6: What is the relationship between the first-order rate constant and saturable elimination?
The elimination equation combines first-order and Michaelis-Menten kinetics, where the first-order rate constant k represents the sum of all first-order elimination processes. The second term signifies the saturable process governed by enzyme kinetics. Together, these components describe mixed elimination where both linear and nonlinear processes occur simultaneously.
Q7: How does glycine availability influence drug conjugation pathways?
Glycine conjugation is a saturable metabolic process where the rate depends on available glycine concentration. When glycine becomes limiting, conjugation capacity plateaus, contributing to nonlinear elimination kinetics. This substrate-dependent saturation exemplifies how metabolic cofactors influence drug elimination and create dose-dependent pharmacokinetic profiles.